← FDA DRUG APPROVALS

FDA ANDA · ANDA203872

LEVONORGESTREL AND ETHINYL ESTRADIOL

Sponsor: NAARI PTE

APPLICATION
ANDA203872
TYPE
ANDA
ORIGINAL APPROVAL
2015-12-22
LATEST ACTION
2023-10-04
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

LEVONORGESTREL AND ETHINYL ESTRADIOLPrescription
ETHINYL ESTRADIOL 0.03MG,0.01MG, LEVONORGESTREL 0.15MG,N/A · TABLET · ORAL

Approval history

2023-10-04Labeling · Supplement 2 · standardAP
2023-10-04Labeling · Supplement 3 · standardAP
2015-12-22UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →